{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:02Z","timestamp":1786118942508,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/iae.0b013e31816079c3","type":"journal-article","created":{"date-parts":[[2008,4,28]],"date-time":"2008-04-28T03:09:36Z","timestamp":1209352176000},"page":"711-716","source":"Crossref","is-referenced-by-count":10,"title":["Effect of Aspirin Therapy on Photodynamic Therapy With Verteporfin for Choroidal Neovascularization"],"prefix":"10.1097","volume":"28","author":[{"given":"TUSHAR M.","family":"RANCHOD","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JASON R.","family":"GUERCIO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GUI-SHUANG","family":"YING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALEXANDER J.","family":"BRUCKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERT A.","family":"STOLTZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials\u2014TAP report.","volume":"117","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R3-6-20210130","first-page":"198","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials\u2014 TAP report.","volume":"119","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R4-6-20210130","article-title":"Visudyne for injection, package insert."},{"key":"R5-6-20210130","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","article-title":"Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.","volume":"240","author":"Schlotzer-Schrehardt","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R6-6-20210130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amepre.2005.08.042","article-title":"Aspirin use among U.S. Adults behavioral risk factor surveillance system.","volume":"30","author":"Ajani","year":"2006","journal-title":"Am J Prev Med"},{"key":"R7-6-20210130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0002-9343(83)90522-3","article-title":"The biologic background to some therapeutic uses of aspirin.","volume":"74","author":"Born","year":"1983","journal-title":"Am J Med"},{"key":"R8-6-20210130","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1751-1097.1993.tb09224.x","article-title":"The effects of aspirin on microvasculature after photodynamic therapy.","volume":"57","author":"Taber","year":"1993","journal-title":"Photochem Photobiol"},{"key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/lsm.1900120507","article-title":"Effect of aspirin on photodynamic therapy utilizing chloroaluminum sulfonated phthalocyanine (CASP).","volume":"12","author":"Stern","year":"1992","journal-title":"Laser Surg Med"},{"key":"R10-6-20210130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1751-1097.1989.tb04179.x","article-title":"The microvascular effects of photodynamic therapy: evidence for a possible role of cyclooxygenase products.","volume":"50","author":"Reed","year":"1989","journal-title":"Photochem Photobiol"},{"key":"R11-6-20210130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00347-005-1256-9","article-title":"Does acetylsalicylic acid have a negative influence on photodynamic therapy?","volume":"103","author":"L\u00f6w","year":"2005","journal-title":"Ophthalmologe"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ophtha.2006.04.039","article-title":"Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization.","volume":"113","author":"Arias","year":"2006","journal-title":"Ophthalmology"},{"key":"R13-6-20210130","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/archopht.124.11.1532","article-title":"Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS study.","volume":"124","author":"Heier","year":"2006","journal-title":"Arch Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0b013e31816079c3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:07:03Z","timestamp":1786036023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-200805000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e31816079c3","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}